Impact of COVID-19 pandemic in pediatric patients with epilepsy with neuropsychiatric comorbidities: A telemedicine evaluation.
Adolescent
COVID-19
/ epidemiology
Child
Child Behavior Disorders
/ epidemiology
Cohort Studies
Communicable Disease Control
/ methods
Epilepsy
/ epidemiology
Female
Humans
Male
Mental Disorders
/ epidemiology
Parents
/ psychology
Prospective Studies
Surveys and Questionnaires
Telemedicine
/ methods
Anxiety
COVID-19
Depression
Epilepsy
Learning disabilities
Neuropsychiatric comorbidities
Journal
Epilepsy & behavior : E&B
ISSN: 1525-5069
Titre abrégé: Epilepsy Behav
Pays: United States
ID NLM: 100892858
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
received:
21
08
2020
revised:
14
09
2020
accepted:
20
09
2020
pubmed:
2
12
2020
medline:
23
2
2021
entrez:
1
12
2020
Statut:
ppublish
Résumé
The objective of this study was to evaluate care needs, emotional and behavioral changes, and parental stress indices in a cohort of pediatric patients with epilepsy with neurocognitive and emotional comorbidities at the time of the coronavirus disease 2019 (COVID-19) pandemic. This is a prospective observational study involving pediatric patients with epilepsy with neurocognitive and emotional comorbidities. Included patients were admitted to our hospital between August 2019 and February 2020 for epilepsy and neuropsychiatric assessment, and Child Behavior Checklist (CBCL) questionnaires were filled in by parents. Those patients and their families accepted to participate in a phone follow-up visit in April-May 2020 and to refill CBCL and Parenting Stress Index-Short Form (PSI-SF) questionnaires. Descriptive statistics for demographic and clinical data, CBCL questionnaire scores before and during the COVID-19 pandemic, and PSI-SF scores have been computed. Moreover, results of a short phone survey on the psychological burden during COVID lockdown have been reported. This study provides the parental-proxy report of emotional and behavioral profile changes of 23 pediatric patients with epilepsy and neurocognitive and emotional comorbidities during the COVID-19 pandemic. Concerns for therapy monitoring at the time of lockdown emerged in 43% of families, and 30% of patients showed worries for an altered contact with the referring medical team. Patients with neurocognitive comorbidities were more likely to exhibit behavioral problems, especially externalizing problems compared with patients with a diagnosis of anxiety/depression. Our data suggest the importance to monitor disease trajectory and behavior and affective symptoms with telehealth strategies to provide effective care to patients and their families.
Identifiants
pubmed: 33257293
pii: S1525-5050(20)30699-5
doi: 10.1016/j.yebeh.2020.107519
pmc: PMC7695947
pii:
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
107519Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest None of the authors has any conflict of interest to disclose.
Références
Semin Pediatr Neurol. 2017 Nov;24(4):276-281
pubmed: 29249507
N Engl J Med. 2020 Mar 26;382(13):1194-1196
pubmed: 32074416
Int J Environ Res Public Health. 2020 Jun 24;17(12):
pubmed: 32599911
J Autism Dev Disord. 2021 May;51(5):1772-1780
pubmed: 32737668
J Neurol Sci. 2020 Jun 15;413:116832
pubmed: 32299017
Nat Rev Neurol. 2016 Aug;12(8):465-76
pubmed: 27448186
Psychol Med. 2022 Apr;52(5):824-833
pubmed: 32571438
Epileptic Disord. 2016 May;18 Suppl 1:1-86
pubmed: 27210239
Epilepsia. 2017 Jul;58(7):1123-1130
pubmed: 28464309
Epilepsy Behav. 2020 Jul;108:107122
pubmed: 32361677
Epilepsy Res. 2016 Nov;127:72-77
pubmed: 27565414
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Neurology. 2020 Jun 9;94(23):1032-1037
pubmed: 32327490
Epilepsia. 2005 May;46(5):720-30
pubmed: 15857439